CYP2D6*36 gene arrangements within the CYP2D6 locus:: Association of CYP2D6*36 with poor metabolizer status

被引:76
作者
Gaedigk, A
Bradford, LD
Alander, SW
Leeder, JS
机构
[1] Childrens Mercy Hosp, Sect Dev Pharmacol & Expt Therapeut, Kansas City, MO 64108 USA
[2] Morehouse Sch Med, Atlanta, GA 30310 USA
关键词
D O I
10.1124/dmd.105.008292
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Unexplained cases of CYP2D6 genotype/ phenotype discordance continue to be discovered. In previous studies, several African Americans with a poor metabolizer phenotype carried the reduced function CYP2D6* 10 allele in combination with a nonfunctional allele. We pursued the possibility that these alleles harbor either a known sequence variation ( i. e., CYP2D6* 36 carrying a gene conversion in exon 9 along the CYP2D6* 10- defining 100C > T single-nucleotide polymorphism) or novel sequences variation( s). Discordant cases were evaluated by long- range polymerase chain reaction ( PCR) to test for gene rearrangement events, and a 6.6-kilobase pair PCR product encompassing the CYP2D6 gene was cloned and entirely sequenced. Thereafter, allele frequencies were determined in different study populations comprising whites, African Americans, and Asians. Analyses covering the CYP2D7 to 2D6 gene region established that CYP2D6* 36 did not only exist as a gene duplication ( CYP2D6* 36x2) or in tandem with * 10 ( CYP2D6* 36 +* 10), as previously reported, but also by itself. This " single" CYP2D6* 36 allele was found in nine African Americans and one Asian, but was absent in the whites tested. Ultimately, the presence of CYP2D6* 36 resolved genotype/ phenotype discordance in three cases. We also discovered an exon 9 conversion- positive CYP2D6* 4 gene in a duplication arrangement ( CYP2D6* 4Nx2) and a CYP2D6* 4 allele lacking 100C > T ( CYP2D6* 4M) in two white subjects. The discovery of an allele that carries only one CYP2D6* 36 gene copy provides unequivocal evidence that both CYP2D6* 36 and * 36x2 are associated with a poor metabolizer phenotype. Given a combined frequency of between 0.5 and 3% in African Americans and Asians, genotyping for CYP2D6* 36 should improve the accuracy of genotype-based phenotype prediction in these populations.
引用
收藏
页码:563 / 569
页数:7
相关论文
共 21 条
[1]   Molecular heterogeneity at the CYP2D gene locus in Nicaraguans: Impact of gene-flow from Europe [J].
Agundez, JAG ;
Ramirez, R ;
Hernandez, M ;
Llerena, A ;
Benitez, J .
PHARMACOGENETICS, 1997, 7 (04) :337-340
[2]  
Alander S. W., 2002, CLIN PHARMACOL THER, V71
[3]   New allelic arrangement CYP2D6*36x2 found in a Japanese poor metabolizer of debrisoquine [J].
Chida, M ;
Ariyoshi, N ;
Yokoi, T ;
Nemoto, N ;
Inaba, M ;
Kinoshita, M ;
Kamataki, T .
PHARMACOGENETICS, 2002, 12 (08) :659-662
[4]   The decreased in vivo clearance of CYP2D6 substrates by CYP2D6*10 might be caused not only by the low-expression but also by low affinity of CYP2D6 [J].
Fukuda, T ;
Nishida, Y ;
Imaoka, S ;
Hiroi, T ;
Naohara, M ;
Funae, Y ;
Azuma, J .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 380 (02) :303-308
[5]   Molecular diversity at the CYP2D6 locus in the Mediterranean region [J].
Fuselli, S ;
Dupanloup, I ;
Frigato, E ;
Cruciani, F ;
Scozzari, R ;
Moral, P ;
Sistonen, J ;
Sajantila, A ;
Barbujani, G .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2004, 12 (11) :916-924
[6]   CYP2D7 splice variants in human liver and brain:: Does CYP2D7 encode functional protein? [J].
Gaedigk, A ;
Gaedigk, R ;
Leeder, JS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 336 (04) :1241-1250
[7]   Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans [J].
Gaedigk, A ;
Bhathena, A ;
Ndjountché, L ;
Pearce, RE ;
Abdel-Rahman, SM ;
Alander, SW ;
Bradford, LD ;
Leeder, JS .
PHARMACOGENOMICS JOURNAL, 2005, 5 (03) :173-182
[8]   Limited association of the 2988G>A single nucleotide polymorphism with CYP2D6*41 in black subjects [J].
Gaedigk, A ;
Ndjountché, L ;
Leeder, JS ;
Bradford, LD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (03) :228-230
[9]   Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D6*42, in African American subjects [J].
Gaedigk, A ;
Ndjountché, L ;
Gaedigk, R ;
Leeder, JS ;
Bradford, LD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (06) :575-576
[10]   CYP2D6 poor metabolizer status can be ruled out by a single genotyping assay for the-1584G promoter polymorphism [J].
Gaedigk, A ;
Ryder, DL ;
Bradford, LD ;
Lceder, JS .
CLINICAL CHEMISTRY, 2003, 49 (06) :1008-1011